DataMeds AI (MEDS) Total Current Liabilities (2023 - 2026)

DataMeds AI (MEDS) has reported Total Current Liabilities for 4 consecutive years, with $32.2 million the latest figure, recorded in Q1 2026.

• For the quarter ending Q1 2026, Total Current Liabilities fell 30.34% year-over-year to $32.2 million; the trailing twelve-month figure through Mar 2026 stood at $32.2 million (down 30.34% YoY), and the FY2025 full-year result was $29.8 million, down 21.73% from the prior year.
• Total Current Liabilities advanced to $32.2 million in Q1 2026 per MEDS's latest filing, from $29.8 million in the prior quarter.
• Across five years, Total Current Liabilities topped out at $46.2 million in Q1 2025 and bottomed at $2.9 million in Q4 2023.
• Historically, Total Current Liabilities has averaged $32.0 million across 4 years, with a median of $32.7 million in 2025.
• The sharpest annual moves came in 2024 and 2026: Total Current Liabilities surged 1217.04% in 2024, then sank 30.34% in 2026.
• Over 4 years, Total Current Liabilities stood at $2.9 million in 2023, then soared by 1217.04% to $38.0 million in 2024, then declined by 21.73% to $29.8 million in 2025, then grew by 8.12% to $32.2 million in 2026.
• According to Business Quant data, Total Current Liabilities over the past three periods registered $32.2 million, $29.8 million, and $32.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.